Clinical Trial Update: GSK372475 PK Study in Healthy Volunteers [Phase 1]

View source ↗

Summary

Phase 1 pharmacokinetic study of GSK372475 in healthy volunteers has been completed, providing PK data for potential depressive disorder treatment.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Major Depressive Disorder

Drugs mentioned

• GSK372475

Snippet

Sponsor: GlaxoSmithKline | Conditions: Depressive Disorder | Phase 1 | Status: COMPLETED